Park, Seongbeom
Ahn, Jehyun
Na, Duk L.
Kim, Hee Jin
Jang, Hyemin
Kim, Jun Pyo
Kang, Sung Hoon
Yun, Jihwan
Chun, Min Young
Seo, Sang Won
Kwak, Kichang
Funding for this research was provided by:
Ministry of Science and ICT, South Korea (RS2020-KH106434)
Korea Health Industry Development Institute (RS-2025-02223212)
National Research Foundation of Korea (RS-2019-NR040057)
Samsung Medical Center, Sungkyunkwan University (SMX1250081)
Korea National Institute of Health (2024ER1003-01)
Article History
Received: 4 October 2025
Accepted: 18 March 2026
First Online: 15 June 2026
Competing interests
: Sang Won Seo is co-founder of BeauBrain Healthcare Inc. Seongbom Park and Kichang Kwak were employed by BeauBrain Healthcare Inc. The other authors declare that they have no competing interests.
: This study was approved by the institutional review board of Samsung Medical Center (Approval no. 2021-02-135). All participants provided informed consent to participate in the study and data were collected in accordance with the Declaration of Helsinki.